Banque Cantonale Vaudoise’s BeOne Medicines Ltd ONC Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-223	Closed	-$49K	–	1233
2022 Q4	$49K	Hold	223	–	–	﹤0.01%	962
2022 Q3	$30K	Buy	223 +3	+1%	+$515	﹤0.01%	1054
2022 Q2	$36K	Buy	220 +48	+28%	+$7.5K	﹤0.01%	1057
2022 Q1	$32K	Sell	172 -989	-85%	-$210K	﹤0.01%	1108
2021 Q4	$315K	Hold	1,161	–	–	0.01%	722
2021 Q3	$421K	Sell	1,161 -1,233	-52%	-$403K	0.02%	616
2021 Q2	$821K	Sell	2,394 -13	-0.5%	-$4.31K	0.04%	473
2021 Q1	$838K	Buy	2,407 +1,407	+141%	+$466K	0.04%	408
2020 Q4	$258K	Hold	1,000	–	–	0.01%	665
2020 Q3	$286K	Hold	1,000	–	–	0.02%	594
2020 Q2	$188K	Hold	1,000	–	–	0.01%	662
2020 Q1	$123K	Buy	+1,000	New	+$156K	0.01%	735

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Banque Cantonale Vaudoise's ONC Position: Q1 2023 in Review

Banque Cantonale Vaudoise sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 223 shares — an estimated $49K sold.

Banque Cantonale Vaudoise first reported a position in ONC in Q1 2020 and held it in 12 quarters. The position peaked at $838K in Q1 2021. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

Banque Cantonale Vaudoise reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
Banque Cantonale Vaudoise sold 223 BeOne Medicines Ltd shares in Q1 2023, an estimated $49K.
Banque Cantonale Vaudoise first reported a position in BeOne Medicines Ltd in Q1 2020 and held it in 12 quarters.
Banque Cantonale Vaudoise's BeOne Medicines Ltd position peaked at $838K in Q1 2021.
220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2023, filed 20 Apr 2023.